In this report, created with the experts at Medpace, we discuss these different challenges emerging biotechs face from surviving a highly competitive environment to addressing funding issues, as well as the importance of defining and adhering to a strategy, working with the regulatory authorities, and the key points to look out for when searching for suitable collaborators.
You will learn
- The challenges emerging biotech companies face from early-stage drug development to commercialization
- The solutions that can help build a winning portfolio strategy, including working with the regulatory authorities
- How to find a suitable partner